where she coordinates and recommends as a voting member of the organization’s Pharmacy and Therapeutics Committee. Prior to her current position, she was co-director of the Illinois Center for ...

As of the submission of this report, Windtree Therapeutics has duly affirmed the appointment of Leanne Kelly as a director and member of the Audit Committee, reinforcing its commitment to ...

The PBM system intentionally blocks lower-cost, FDA-approved biosimilars from being available to patients. Biosimilars are the commonsense, bipartisan solution to out-of-control prescription drug ...

A recent NAPA article notes key priorities of the Senate Committee on Health, Education, Labor, and Pensions (HELP), now ...

The newly formed company will be named Decoy Therapeutics. This proposed transaction is expected to facilitate multiple value-creating inflection points with Decoy’s pipeline of peptide ...

Entered into agreements for warrant inducement transaction expected to result in up to $20.4 million in gross proceeds ISELIN, N.J., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics ...

Pliant Therapeutics has pumped the breaks on a midstage trial of its lead lung disease drug on the advice of its safety committee. The South San Francisco biotech has been evaluating 160-mg and ...

Coya Therapeutics, Inc. has Treg therapies for neurodegenerative and autoimmune diseases, targeting ALS, FTD, AD, and PD. However, their lead candidate is now clearly COYA 302. This drug basically ...

Odyssey Therapeutics and Sionna Therapeutics have filed IPO paperwork, swelling the pack of startups that will provide an early look at how receptive public investors could be to biotech listings ...

However, Wall Street's enthusiasm for Summit Therapeutics appears to be justified. If ivonescimab fulfills its potential, Summit should be worth a lot more within a few years than it is today.

In a report released today, Reni Benjamin from JMP Securities reiterated a Buy rating on Summit Therapeutics (SMMT – Research Report), with a price target of $32.00. Reni Benjamin has given his ...